{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:22:16Z","timestamp":1781104936003,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Iron-overloaded patients are recognized as presenting an increased risk of osteoporosis. However, studies on the correlation between osteoporosis and organ iron overload are controversial or scarce. The aim of this study is to assess bone mineral density (BMD) and trabecular bone score (TBS) in correlation with hepatic and pancreatic iron overload.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Forty-one patients diagnosed with hemoglobinopathies, were studied. BMDs of the lumbar spine (LS), femoral neck (FN), and total hip (TH) were analyzed by Dual-energy X-ray absorptiometry (DXA) scan. LS bone quality was derived from each spine DXA examination using the TBS analysis. Hepatic and pancreatic iron overload were obtained with a multi-echo gradient echo T2* technique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Abnormal microarchitecture and abnormal bone mass were observed in 19\/41 (46.3%) and 9\/41 (22.0%) patients, respectively. For 26 males, BMD, T-score and Z-score of LS were significantly lower among subjects with moderate-severe hepatic iron-overload than their counterparts, as it is between no- and pancreatic iron-overload groups. For 15 females, patients with moderate-severe hepatic iron-overload had significantly lower BMD and T-score of FN and TH, and patients with pancreatic iron-overload had significantly lower BMD, T-score of FN, and lower BMD, T-score and Z-score of TH than their counterparts. Moreover, pancreatic T2*-value was positively correlated with BMD and T-score at all analyzed sites and Z-score at TH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These data showed lower bone mass in patients with organ iron overload, particularly for LS in males, FN and TH in females. TBS may well represent a complementary tool for the evaluation of bone quality and the risk of fracture in iron-overloaded patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-022-01262-6","type":"journal-article","created":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T03:04:33Z","timestamp":1672715073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of hepatic\/pancreatic iron overload evaluated by quantitative T2* MRI with bone mineral density and trabecular bone score"],"prefix":"10.1186","volume":"23","author":[{"given":"Zaizhu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengtao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"1262_CR1","first-page":"447","volume":"83","author":"A Piperno","year":"1998","unstructured":"Piperno A. Classification and diagnosis of iron overload. Haematologica. 1998;83:447\u201355.","journal-title":"Haematologica"},{"key":"1262_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1148\/rg.2018170079","volume":"38","author":"R Labranche","year":"2018","unstructured":"Labranche R, Gilbert G, Cerny M, Vu KN, Soulieres D, Olivie D, et al. Liver Iron quantification with MR imaging: a primer for radiologists. Radiographics. 2018;38:392\u2013412.","journal-title":"Radiographics"},{"key":"1262_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s10534-006-9000-8","volume":"19","author":"ED Weinberg","year":"2006","unstructured":"Weinberg ED. Iron loading: a risk factor for osteoporosis. Biometals. 2006;19:633\u20135.","journal-title":"Biometals"},{"issue":"2","key":"1262_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12011-019-01867-4","volume":"195","author":"J Che","year":"2020","unstructured":"Che J, Yang J, Zhao B, Zhang G, Wang L, Peng S, et al. The effect of abnormal Iron metabolism on osteoporosis. Biol Trace Elem Res. 2020;195(2):353\u201365.","journal-title":"Biol Trace Elem Res"},{"key":"1262_CR5","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9:1137\u201341.","journal-title":"J Bone Miner Res"},{"key":"1262_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bone.2016.12.016","volume":"104","author":"HP Dimai","year":"2017","unstructured":"Dimai HP. Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment; WHO-criteria, T- and Z-score, and reference databases. Bone. 2017;104:39\u201343.","journal-title":"Bone"},{"key":"1262_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/BF03350919","volume":"27","author":"L Dalle Carbonare","year":"2004","unstructured":"Dalle Carbonare L, Giannini S. Bone microarchitecture as an important determinant of bone strength. J Endocrinol Investig. 2004;27:99\u2013105.","journal-title":"J Endocrinol Investig"},{"key":"1262_CR8","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","volume":"164","author":"ES Siris","year":"2004","unstructured":"Siris ES, Chen YT, Abbott TA, Barrett-Connor E, Miller PD, Wehren LE, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164:1108\u201312.","journal-title":"Arch Intern Med"},{"key":"1262_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ecl.2016.09.005","volume":"46","author":"BC Silva","year":"2017","unstructured":"Silva BC, Leslie WD. Trabecular bone score: a new DXA-derived measurement for fracture risk assessment. Endocrinol Metab Clin N Am. 2017;46:153\u201380.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"1262_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.5603\/EP.a2019.0022","volume":"70","author":"J Halupczok-\u017by\u0142a","year":"2019","unstructured":"Halupczok-\u017by\u0142a J, Gojny \u0141, Bolanowski M. Trabecular bone score (TBS) as a noninvasive and complementary tool for clinical diagnosis of bone structure in endocrine disorders. Endokrynol Pol. 2019;70:350\u20136.","journal-title":"Endokrynol Pol"},{"key":"1262_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12020-021-02806-x","volume":"74","author":"E Shevroja","year":"2021","unstructured":"Shevroja E, Cafarelli FP, Guglielmi G, Hans D. DXA parameters, trabecular bone score (TBS) and bone mineral density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis. Endocrine. 2021;74:20\u20138.","journal-title":"Endocrine"},{"key":"1262_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00277-017-2959-0","volume":"96","author":"M Baldini","year":"2017","unstructured":"Baldini M, Marcon A, Ulivieri FM, Seghezzi S, Cassin R, Messina C, et al. Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables. Ann Hematol. 2017;96:995\u20131003.","journal-title":"Ann Hematol"},{"issue":"9","key":"1262_CR13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3390\/genes12091304","volume":"12","author":"K Banaszkiewicz","year":"2021","unstructured":"Banaszkiewicz K, Sikorska K, Panas D, Sworczak K. The role of the trabecular bone score in the assessment of Osteoarticular disorders in patients with HFE-hemochromatosis: a single-center study from Poland. Genes (Basel). 2021;12(9):1304.","journal-title":"Genes (Basel)"},{"key":"1262_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00198-008-0701-4","volume":"20","author":"L Valenti","year":"2009","unstructured":"Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int. 2009;20:549\u201355.","journal-title":"Osteoporos Int"},{"key":"1262_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1179\/1607845412Y.0000000013","volume":"17","author":"L Ebrahimpour","year":"2012","unstructured":"Ebrahimpour L, Akhlaghpoor S, Azarkayvan A, Salehi M, Morteza A, Alinaghi R. Correlation between bone mineral densitometry and liver\/heart iron overload evaluated by quantitative T2* MRI. Hematology. 2012;17:297\u2013301.","journal-title":"Hematology"},{"key":"1262_CR16","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s00198-005-1934-0","volume":"16","author":"P Guggenbuhl","year":"2005","unstructured":"Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int. 2005;16:1809\u201314.","journal-title":"Osteoporos Int"},{"key":"1262_CR17","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3324\/haematol.2011.047852","volume":"96","author":"KM Musallam","year":"2011","unstructured":"Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, et al. Elevated liver iron concentration is a marker of increased morbidity in patients with beta thalassemia intermedia. Haematologica. 2011;96:1605\u201312.","journal-title":"Haematologica"},{"key":"1262_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","volume":"18","author":"BC Silva","year":"2015","unstructured":"Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD. Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 2: trabecular bone score. J Clin Densitom. 2015;18:309\u201330.","journal-title":"J Clin Densitom"},{"key":"1262_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF01622200","volume":"4","author":"JA Kanis","year":"1994","unstructured":"Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO study group. Osteoporos Int. 1994;4:368\u201381.","journal-title":"Osteoporos Int"},{"key":"1262_CR20","unstructured":"Adult official positions of the international society for clinical Densitometry. 2020. http:\/\/www.iscd.org\/offcial positions\/offcial. ISCD position-adult (English)."},{"key":"1262_CR21","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","volume":"31","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Od\u00e9n A, Harvey NC, Leslie WD, Hans D, Johansson H, et al. A Meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res. 2016;31:940\u20138.","journal-title":"J Bone Miner Res"},{"key":"1262_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJM200008033430503","volume":"343","author":"E Angelucci","year":"2000","unstructured":"Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343:327\u201331.","journal-title":"N Engl J Med"},{"key":"1262_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3324\/haematol.11768","volume":"93","author":"WY Au","year":"2008","unstructured":"Au WY, Lam WW, Chu W, Tam S, Wong WK, Liang R, et al. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica. 2008;93:116\u20139.","journal-title":"Haematologica"},{"key":"1262_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res. 2014;29:518\u201330.","journal-title":"J Bone Miner Res"},{"key":"1262_CR25","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3324\/haematol.2011.047852","volume":"96","author":"KM Musallam","year":"2011","unstructured":"Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, et al. Elevated liver iron concentration is a marker of increased morbidity in patients with \u03b2 thalassemia intermedia. Haematologica. 2011;96:1605\u201312.","journal-title":"Haematologica"},{"key":"1262_CR26","doi-asserted-by":"publisher","first-page":"e3448","DOI":"10.1002\/dmrr.3448","volume":"37","author":"H Wu","year":"2021","unstructured":"Wu H, Yu M, Xiao C, Zhang Q, Xiao X. Clinical characteristics of endocrinopathies in Chinese patients with hereditary haemochromatosis. Diabetes Metab Res Rev. 2021;37:e3448.","journal-title":"Diabetes Metab Res Rev"},{"key":"1262_CR27","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2265.2012.04495.x","volume":"78","author":"MK Kim","year":"2013","unstructured":"Kim MK, Lee JW, Baek KH, Song KH, Kwon HS, Oh KW, et al. Endocrinopathies in transfusion-associated iron overload. Clin Endocrinol. 2013;78:271\u20137.","journal-title":"Clin Endocrinol"},{"key":"1262_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10238-021-00735-7","volume":"22","author":"C Sevimli","year":"2022","unstructured":"Sevimli C, Yilmaz Y, Bayramoglu Z, Comert RG, Gul N, Dursun M, et al. Pancreatic MR imaging and endocrine complications in patients with beta-thalassemia: a single-center experience. Clin Exp Med. 2022;22:95\u2013101.","journal-title":"Clin Exp Med"},{"key":"1262_CR29","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1007\/s00330-019-06487-z","volume":"30","author":"J Shur","year":"2020","unstructured":"Shur J, Kannengiesser SAR, Menezes R, Ward R, Kuo K, Jhaveri K. Glucose dysregulation in patients with iron overload: is there a relationship with quantitative pancreas and liver iron and fat content measured by MRI? Eur Radiol. 2020;30:1616\u201323.","journal-title":"Eur Radiol"},{"key":"1262_CR30","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s00261-020-02912-w","volume":"46","author":"E Aslan","year":"2021","unstructured":"Aslan E, Luo JW, Lesage A, Paquin P, Cerny M, Chin AS, et al. MRI-based R2* mapping in patients with suspected or known iron overload. Abdom Radiol (NY). 2021;46:2505\u201315.","journal-title":"Abdom Radiol (NY)"},{"key":"1262_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4274\/tjh.2015.0142","volume":"33","author":"\u0130S \u0130dilman","year":"2016","unstructured":"\u0130dilman \u0130S, G\u00fcmr\u00fck F, Halilo\u011flu M, Kar\u00e7aalt\u0131ncaba M. The feasibility of magnetic resonance imaging for quantification of liver, pancreas, spleen, vertebral bone marrow, and renal cortex R2* and proton density fat fraction in transfusion-related Iron overload. Turk J Haematol. 2016;33:21\u20137.","journal-title":"Turk J Haematol"},{"key":"1262_CR32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/jmri.21707","volume":"29","author":"O Papakonstantinou","year":"2009","unstructured":"Papakonstantinou O, Alexopoulou E, Economopoulos N, Benekos O, Kattamis A, Kostaridou S, et al. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major. J Magn Reson Imaging. 2009;29:853\u20139.","journal-title":"J Magn Reson Imaging"},{"key":"1262_CR33","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s00330-007-0683-1","volume":"17","author":"MI Argyropoulou","year":"2007","unstructured":"Argyropoulou MI, Kiortsis DN, Astrakas L, Metafratzi Z, Chalissos N, Efremidis SC. Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study. Eur Radiol. 2007;17:3025\u201330.","journal-title":"Eur Radiol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01262-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-01262-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-01262-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T17:04:17Z","timestamp":1673024657000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-01262-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1262"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-01262-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2013546\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective study was approved by the Medical Ethics Committee of the Peking Union Medical College Hospital, in line with the Declaration of Helsinki and written informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}